EP4255393
STAÐBUNDIN ROFLUMILAST FORMÚLA MEÐ SVEPPAEYÐANDI EIGINLEIKUM
:
EP einkaleyfi í gildi á Íslandi:
3.12.2021:
28.5.2025:
21840242.8
:
25.6.2025:
15.7.2025
:
2.12.2041:
2.12.2025
:
TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES
3.12.2021
28.5.2025
25.6.2025
15.7.2025
2.12.2025
:
Arcutis Biotherapeutics, Inc.:
3027 Townsgate Road, Suite 300, Westlake Village, CA 91361, US
:
KATO, Saori:
Westlake Village, California 91361, US
:
BERK, David Reuben:
Westlake Village, California 91361, US
:
BURNETT, Patrick Eugene:
Westlake Village, California 91361, US
:
OSBORNE, David:
Fort Collins, Colorado 80525, US
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
202063121299 P:
4.12.2020:
US
:
US2021061871:
3.12.2021
:
A61K 31/137, A61K 9/00, A61K 31/201, A61K 31/343, A61K 31/4174, A61K 31/44, A61K 31/496, A61K 31/506, A61K 31/513, A61K 31/60, A61K 33/04, A61K 45/06, A61P 17/00, A61P 17/04, A61P 31/10, A61K 9/107, A61K 9/12